ES8801373A1 - Un procedimiento para aislar un gen de preprorrelaxina -h2 humana o un equivalente o subunidad del mismo - Google Patents

Un procedimiento para aislar un gen de preprorrelaxina -h2 humana o un equivalente o subunidad del mismo

Info

Publication number
ES8801373A1
ES8801373A1 ES552095A ES552095A ES8801373A1 ES 8801373 A1 ES8801373 A1 ES 8801373A1 ES 552095 A ES552095 A ES 552095A ES 552095 A ES552095 A ES 552095A ES 8801373 A1 ES8801373 A1 ES 8801373A1
Authority
ES
Spain
Prior art keywords
human
gene
subunit
isolating
transfer vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES552095A
Other languages
English (en)
Other versions
ES552095A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florey Institute of Neuroscience and Mental Health
Original Assignee
Howard Florey Institute of Experimental Physiology and Medicine
Florey Institute of Neuroscience and Mental Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3769889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8801373(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Howard Florey Institute of Experimental Physiology and Medicine, Florey Institute of Neuroscience and Mental Health filed Critical Howard Florey Institute of Experimental Physiology and Medicine
Publication of ES552095A0 publication Critical patent/ES552095A0/es
Publication of ES8801373A1 publication Critical patent/ES8801373A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA AISLAR UN GEN DE PREPRORRELAXINA-H2 HUMANA O UN EQUIVALENTE O SUBUNIDAD DEL MISMO. COMPRENDE LAS OPERACIONES DE FORMAR UN VECTOR DE TRANSFERENCIA RECOMBINANTE MEDIANTE LAS ACCIONES DE AISLAR MARN DE TEJIDO HUMANO QUE EXPRESA RELAXINA, DE PREPARAR ADN DE DOBLE CADENA A PARTIR DE DICHO MARN Y DE INSERTAR EL CADN EN UN VECTOR DE TRANSFERENCIA APROPIADO, PARA OBTENER UN VECTOR DE TRANSFERENCIA RECOMBINANTE; DE TRANSFORMAR CELULAS HOSPEDANTES CON EL VECTOR O VECTORES DE TRANSFERENCIA RECOMBINANTES; Y DE HIBRIDAR EL VECTOR O VECTORES DE TRANSFERENCIA RECOMBINANTES CON UNA SONDA DE HIBRIDACION MARCADA CORRESPONDIENTE A UNA SUBUNIDAD O FRAGMENTO DEL GEN DE RELAXINA-H1 HUMANA PARA IDENTIFICAR EL GEN DE PREPRORRELAXINA-H2 HUMANA.
ES552095A 1982-12-13 1986-02-17 Un procedimiento para aislar un gen de preprorrelaxina -h2 humana o un equivalente o subunidad del mismo Expired ES8801373A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPF724782 1982-12-13

Publications (2)

Publication Number Publication Date
ES552095A0 ES552095A0 (es) 1987-12-16
ES8801373A1 true ES8801373A1 (es) 1987-12-16

Family

ID=3769889

Family Applications (6)

Application Number Title Priority Date Filing Date
ES527964A Expired ES8602133A1 (es) 1982-12-13 1983-12-12 Un procedimiento para preparar un vector de transferencias de adn
ES544293A Expired ES8802249A1 (es) 1982-12-13 1985-06-17 Un procedimiento para el aislamiento de un gen de relaxina de un ser humano u otro primate o de una especie relacionada
ES552093A Expired ES8708016A1 (es) 1982-12-13 1986-02-17 Un procedimiento para sintetizar una secuencia de aminoacidos que contienen la totalidad o parte de la secuencia de aminoacidos de la preprorrelaxina -h2 humana.
ES552094A Expired ES8708015A1 (es) 1982-12-13 1986-02-17 Un procedimiento para preparar relaxina -h2 humana o uno de sus analogos
ES552095A Expired ES8801373A1 (es) 1982-12-13 1986-02-17 Un procedimiento para aislar un gen de preprorrelaxina -h2 humana o un equivalente o subunidad del mismo
ES557531A Expired ES8801675A1 (es) 1982-12-13 1987-05-11 Un procedimiento para preparar relaxina-h2 humana

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES527964A Expired ES8602133A1 (es) 1982-12-13 1983-12-12 Un procedimiento para preparar un vector de transferencias de adn
ES544293A Expired ES8802249A1 (es) 1982-12-13 1985-06-17 Un procedimiento para el aislamiento de un gen de relaxina de un ser humano u otro primate o de una especie relacionada
ES552093A Expired ES8708016A1 (es) 1982-12-13 1986-02-17 Un procedimiento para sintetizar una secuencia de aminoacidos que contienen la totalidad o parte de la secuencia de aminoacidos de la preprorrelaxina -h2 humana.
ES552094A Expired ES8708015A1 (es) 1982-12-13 1986-02-17 Un procedimiento para preparar relaxina -h2 humana o uno de sus analogos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557531A Expired ES8801675A1 (es) 1982-12-13 1987-05-11 Un procedimiento para preparar relaxina-h2 humana

Country Status (14)

Country Link
US (1) US4758516A (es)
EP (2) EP0303033B1 (es)
JP (3) JP2545055B2 (es)
KR (1) KR940002536B1 (es)
AT (2) ATE90360T1 (es)
CA (1) CA1220735A (es)
DE (1) DE3382249D1 (es)
DK (2) DK171684B1 (es)
ES (6) ES8602133A1 (es)
HU (1) HU197767B (es)
IE (1) IE63902B1 (es)
IL (1) IL70414A (es)
NZ (1) NZ206534A (es)
ZA (1) ZA839231B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382117D1 (de) * 1982-08-12 1991-02-21 Florey Howard Inst Molekulare klonierung und charakterisierung der das menschliche relaxin kodierenden gen-sequenz.
US5179195A (en) * 1982-12-13 1993-01-12 Howard Florey Institute Of Experimental Physiology And Medicine Human relaxin polypeptides
US4835251A (en) * 1986-06-23 1989-05-30 Genetech, Inc. Method of chain combination
NZ221789A (en) * 1986-09-12 1991-05-28 Genentech Inc Recombinant prorelaxin, its preparation and pharmaceutical compositions comprising it
DE68906153T2 (de) * 1988-02-26 1993-10-28 Genentech Inc Humanes relaxinpräparat.
WO1990013659A1 (en) * 1989-05-04 1990-11-15 Genentech, Inc. Processes and compositions for the isolation of human relaxin
US5089419A (en) * 1989-08-07 1992-02-18 International Canine Genetics Detection of pregnancy by identification of the c peptide of relaxin in the urine of animals
US5478807A (en) * 1991-08-19 1995-12-26 Genentech, Inc. Use of relaxin in the treatment of bradycardia
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy
CA2121683A1 (en) * 1991-10-28 1993-05-13 Reuben Lotan A method for detecting a differentiation marker in normal and carcinoma cells and in biological samples and body fluid
US6348327B1 (en) 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
EP0707650B1 (en) * 1993-06-21 2003-05-21 Genentech, Inc. Process for producing human relaxin
US20050032683A1 (en) * 2000-10-04 2005-02-10 Amento Edward P. Methods of modulating apoptosis by administration of relaxin agonists or antagonists
US20040006205A1 (en) * 2001-04-03 2004-01-08 Li Li Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2456753A1 (en) * 2001-08-17 2003-02-27 The Board Of Trustees Of The Leland Stanford Junior University Mammalian relaxin receptors
AU2003903124A0 (en) * 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
CA2563433C (en) * 2004-04-30 2010-07-13 Bas Medical, Inc. Methods and compositions for control of fetal growth via modulation of relaxin
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
PT2288367E (pt) * 2008-05-16 2016-02-09 Corthera Inc Relaxina h2 para utilização no tratamento da dilatação cervical prematura
GR1006941B (el) 2009-06-01 2010-08-27 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Πεπτιδικη συνθεση (peptide synthesis)
US8389475B2 (en) * 2009-08-10 2013-03-05 The Board Of Trustees Of The Leland Stanford Junior University Relaxin analogs
MA34521B1 (fr) 2010-08-17 2013-09-02 Ambrx Inc Polypeptides de relaxine modifiés et leurs utilisations
EP2726502A1 (en) * 2011-07-01 2014-05-07 Bayer Intellectual Property GmbH Relaxin fusion polypeptides and uses thereof
EP2630964A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Method and medicament for treating patients in risk of prediabetes and type-2 diabetes
WO2015073727A1 (en) 2013-11-13 2015-05-21 Aequus Biopharma, Inc. Engineered glycoproteins and uses thereof
EP2946788A1 (en) 2014-05-23 2015-11-25 Immundiagnostik AG Method and composition for treating heart failure with preserved ejection fraction
KR20230074598A (ko) 2016-05-18 2023-05-30 모더나티엑스, 인크. 릴랙신을 인코딩하는 폴리뉴클레오타이드
CN110637027B (zh) 2017-02-08 2024-08-30 百时美施贵宝公司 包含药代动力学增强子的修饰的松弛素多肽及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468464A (en) * 1974-11-04 1984-08-28 The Board Of Trustees Of The Leland Stanford Junior University Biologically functional molecular chimeras
GR70279B (es) * 1979-09-12 1982-09-03 Univ California
US4267101A (en) * 1980-02-01 1981-05-12 Serono Laboratories Inc. Process for obtaining human relaxin from fetal membranes
EP0068375A3 (en) * 1981-06-22 1983-04-13 G.D. Searle & Co. Recombinant dna techniques for the production of relaxin
IE55479B1 (en) * 1982-02-12 1990-09-26 Florey Howard Inst Molecular cloning and characterization of the gene sequence coding for porcine relaxin
DE3382117D1 (de) * 1982-08-12 1991-02-21 Florey Howard Inst Molekulare klonierung und charakterisierung der das menschliche relaxin kodierenden gen-sequenz.

Also Published As

Publication number Publication date
ES8801675A1 (es) 1988-02-16
DK573783A (da) 1984-06-14
DE3382249D1 (de) 1991-05-16
ES557531A0 (es) 1988-02-16
JPH06100585A (ja) 1994-04-12
DK573783D0 (da) 1983-12-13
JPS59156284A (ja) 1984-09-05
EP0303033A3 (en) 1989-10-25
HU197767B (en) 1989-05-29
ES544293A0 (es) 1988-04-16
DK143492A (da) 1992-11-30
ES8802249A1 (es) 1988-04-16
NZ206534A (en) 1988-05-30
ATE90360T1 (de) 1993-06-15
IE832908L (en) 1984-06-13
DK172012B1 (da) 1997-09-15
ES552093A0 (es) 1987-09-01
ES552094A0 (es) 1987-09-01
US4758516A (en) 1988-07-19
IE63902B1 (en) 1995-06-14
JP2545055B2 (ja) 1996-10-16
EP0112149B1 (en) 1991-04-10
DK171684B1 (da) 1997-03-10
JP2677332B2 (ja) 1997-11-17
ES8708016A1 (es) 1987-09-01
KR840007024A (ko) 1984-12-04
IL70414A0 (en) 1984-03-30
ES552095A0 (es) 1987-12-16
IL70414A (en) 1991-06-10
ES8708015A1 (es) 1987-09-01
CA1220735A (en) 1987-04-21
EP0112149A2 (en) 1984-06-27
JPH07173198A (ja) 1995-07-11
DK143492D0 (da) 1992-11-30
ES527964A0 (es) 1985-11-16
ATE62507T1 (de) 1991-04-15
ES8602133A1 (es) 1985-11-16
EP0303033A2 (en) 1989-02-15
JP2891882B2 (ja) 1999-05-17
ZA839231B (en) 1984-08-29
EP0112149A3 (en) 1985-05-22
KR940002536B1 (ko) 1994-03-25
EP0303033B1 (en) 1993-06-09

Similar Documents

Publication Publication Date Title
ES8801373A1 (es) Un procedimiento para aislar un gen de preprorrelaxina -h2 humana o un equivalente o subunidad del mismo
ES8802160A1 (es) Un procedimiento para aislar un gen de relaxina cromosomica de un ser humano o de otro primate o una especie afin
ES2056115T3 (es) Medios y metodos para mejorar la hibridacion de un acido nucleico.
ES2243007T3 (es) Sintesis quimica completa y sintesis de genes de genomas.
ES2056817T3 (es) Transformacion de trichoderma.
CL2004001483A1 (es) Procedimiento para producir una celula vegetal y un cultivo de estas, que son resistentes o tolerantes a un herbicida que inhibe a la glutamina sintetasa mediante la introduccion de un gen que codifica una acetil-transferasa; metodo para producir una
ES2103001T3 (es) Vacunas.
MXPA01003344A (es) Composiciones y metodos para inmunoterapia especifica de wt1.
CO4600706A1 (es) Genes sinteticos del vih
ES2054638T3 (es) Gen codificante de los factores humanos de estimulacion colonial.
DK1448229T3 (da) Farmaceutisk sammensætning til at inducere et immunrespons hos et menneske eller et dyr
ES2103819T3 (es) Metodo para el diagnostico del virus del papiloma humano tipo 16 utilizando la reaccion en cadena de la polimerasa.
ES2163037T3 (es) Empleo de amidas del acido poliasparaginico a modo de agentes auxiliares para el cuero.
ES8202586A1 (es) Un procedimiento para clonar una secuencia de desoxinucleo- tidos
ES2026206T3 (es) Procedimiento para mejorar la expresion de proteina de eucariota.
MX2023001287A (es) Bancos universales de células t específicas de antígeno y métodos de fabricación y uso terapéutico de los mismos.
ES2123753T3 (es) Vectores retroviricos para el tratamiento de tumores y lineas celulares que los contienen.
ATE386130T1 (de) Adenovirale vektoren für die gentherapie
ATE2276T1 (de) Vectoren die geeignet sind zur einfuegung in ihre genome von fremden dns-fragmenten, in jeder der moeglichen uebergangsphasen, und mittel zu ihrer herstellung.
IT7927401A0 (it) Serie di particolari di endoprotesi e procedimento per l'adattamento della lunghezza del collarino di questa endoprotesi.
NO793192L (no) 4-fenyl-1,3-benzodiazepiner og fremgangsmaate til deres fremstilling.
ES2054880T3 (es) Metodo de detectar tumores que contengan un defecto genetico del retinoblastoma.
ES2061719T3 (es) Proceso para la produccion de proteinas.
CO5280143A1 (es) Mutantes de ehv gm-negativa
PT87940A (pt) Processo para a preparacao de dna do virus papillom humano tipo 41 e de proteinas por ele codificadas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20051028